A large-scale observational study published in 2023 analyzed electronic health records of over 80,000 patients with obesity and found that those prescribed semaglutide had a 50-56% lower risk of alcohol use disorder compared to those on other obesity medications
The Revivify Approach to Avli At Revivify Medical Spa, we approach cellulite treatment with honesty, education, and compassion
Testosterone deficiency in adults and corresponding treatment patterns across the globe
Gallbladder Diseases - Incidences of acute gallbladder diseases such as cholelithiasis and cholecystitis have been reported in clinical trials of patients treated with Semaglutide as well as placebo-treated individuals
beyond-use dates Before we dive into the risks, it's important to understand what those dates on your medication actually mean
Even among patients with diabetes, where the clinical case for continued treatment was strongest, 46.5 percent stopped within 12 months